Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$11.27 - $13.53 $442,899 - $531,715
-39,299 Reduced 99.96%
16 $0
Q4 2023

Feb 12, 2024

BUY
$8.77 - $10.85 $315,395 - $390,198
35,963 Added 1072.88%
39,315 $425,000
Q3 2023

Nov 02, 2023

BUY
$9.59 - $11.35 $220 - $261
23 Added 0.69%
3,352 $33,000
Q2 2023

Aug 14, 2023

BUY
$9.02 - $10.29 $29,702 - $33,884
3,293 Added 9147.22%
3,329 $33,000
Q1 2023

May 03, 2023

BUY
$9.2 - $12.26 $303 - $404
33 Added 1100.0%
36 $0
Q4 2022

Feb 03, 2023

SELL
$8.72 - $11.56 $148 - $196
-17 Reduced 85.0%
3 $0
Q4 2021

Jan 21, 2022

SELL
$12.09 - $14.68 $181 - $220
-15 Reduced 42.86%
20 $0
Q3 2021

Nov 10, 2021

BUY
$13.25 - $15.13 $198 - $226
15 Added 75.0%
35 $0
Q4 2020

Jan 29, 2021

BUY
$14.3 - $18.74 $286 - $374
20 New
20 $0

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Tfo Tdc, LLC Portfolio

Follow Tfo Tdc, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfo Tdc, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tfo Tdc, LLC with notifications on news.